SCHEMBL9949480

SCHEMBL9949480

CCCCCCCCCCCCCCC1[CH]CCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.39
CYP1A2 P05177 3/20 0.39
ALDH1A1 P00352 1/20 0.38
NAAA Q02083 3/20 0.37
CHRNB2 P17787 1/20 0.35
CHRNA7 P36544 1/20 0.35
CHRNA4 P43681 1/20 0.35
PSMB11 A5LHX3 1/20 0.32
PSMA7 O14818 1/20 0.32
PSMB1 P20618 1/20 0.32
PSMA1 P25786 1/20 0.32
PSMA2 P25787 1/20 0.32
PSMA3 P25788 1/20 0.32
PSMA4 P25789 1/20 0.32
PSMB8 P28062 1/20 0.32
PSMB9 P28065 1/20 0.32
PSMA5 P28066 1/20 0.32
PSMB4 P28070 1/20 0.32
PSMB6 P28072 1/20 0.32
PSMB5 P28074 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9948824 1.00 EPHX1 (0.39) EPHX1CYP1A2ALDH1A1NAAACHRNB2
SCHEMBL5688099 1.00 EPHX1 (0.39) EPHX1CYP1A2ALDH1A1NAAACHRNB2
SCHEMBL9979248 1.00 EPHX1 (0.39) EPHX1CYP1A2ALDH1A1NAAACHRNB2
SCHEMBL9950636 1.00 EPHX1 (0.39) EPHX1CYP1A2ALDH1A1NAAACHRNB2
SCHEMBL7201664 1.00 EPHX1 (0.39) EPHX1CYP1A2ALDH1A1NAAACHRNB2
SCHEMBL9980541 1.00 EPHX1 (0.39) EPHX1CYP1A2ALDH1A1NAAACHRNB2
SCHEMBL9591949 0.98 CYP1A2 (0.40) EPHX1CYP1A2ALDH1A1NAAACHRNB2
SCHEMBL4450962 0.94 EPHX1 (0.41) EPHX1CYP1A2ALDH1A1NAAACHRNB2
SCHEMBL9214351 0.94 EPHX1 (0.41) EPHX1CYP1A2ALDH1A1NAAACHRNB2
SCHEMBL9474195 0.94 EPHX1 (0.41) EPHX1CYP1A2ALDH1A1NAAACHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104479055-B A kind of dialkoxy-magnesium support type ingredient of solid catalyst and catalyst 任丘市利和科技发展有限公司 2017-06-06 CN claimed
CN-110036068-A Concentrate composition 巴塞尔聚烯烃意大利有限公司 2019-07-19 CN disclosed
CN-108117617-A A kind of ingredient of solid catalyst and catalyst for olefinic polymerization 任丘市利和科技发展有限公司 2018-06-05 CN disclosed
CN-107417819-A A kind of ingredient of solid catalyst, catalyst and its application for olefinic polymerization 北京利和知信科技有限公司 2017-12-01 CN disclosed
CN-107417818-A It is a kind of for the catalytic component of olefinic polymerization, preparation method and catalyst 北京利和知信科技有限公司 2017-12-01 CN disclosed
CN-104479055-B A kind of dialkoxy-magnesium support type ingredient of solid catalyst and catalyst 任丘市利和科技发展有限公司 2017-06-06 CN disclosed
EP-2479159-A1 PREPARATION METHOD FOR COMPOUND PROVIDED WITH DOUBLE BOND Sumitomo Chemical Co., Ltd (JP) 2012-07-25 EP disclosed
US-20120165587-A1 Method for Producing a Compound with a Double Bond SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165587-A1 Method for Producing a Compound with a Double Bond ADH1C, ADH1A, ADH5 EPHX1 1502/4885CYP1A2 98/4885ALDH1A1 110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.